Advertisement

Internal and Emergency Medicine

, Volume 13, Issue 5, pp 673–678 | Cite as

Emergency Department influenza vaccination campaign allows increasing influenza vaccination coverage without disrupting time interval quality indicators

  • Enrique Casalino
  • Aiham Ghazali
  • Donia Bouzid
  • Stephanie Antoniol
  • Philippe Kenway
  • Laurent Pereira
  • Christophe Choquet
  • Emergency Department Study Group on Respiratory Viruses
IM - ORIGINAL
  • 49 Downloads

Abstract

To evaluate the impact of an influenza vaccination (IV) coverage (IVC) in a vaccination campaign of an Emergency Department (EDVC) and its impact on ED time interval quality indicators. We conducted a 4 year observational study, with an intervention during the 4th year. IVC was calculated during pre-and early-epidemic periods. During the final period, a 12 weeks EDVC was implemented. Physicians and nurses were trained and sensitized in the importance of vaccination, and their role in the prevention of severe forms of influenza was reinforced. The vaccine was proposed by physicians and nurses, and delivered by them. Repeated measures ANOVA is a validated method for related not independent groups (https://statistics.laerd.com/statistical-guides/repeated-measures-anova-statistical-guide.php). Overall, IVC was 987/3191 (30.9%) with an increasing trend from 28.8 to 33.2%. In the fourth period, out of 868 patients identified with IV indication, 288 had already been vaccinated (IVC 33.2%). After excluding patients presenting criteria of exclusion, IV was proposed to 475 patients: 317 (66.7%) accepted. The vaccination rate after patient’s acceptance was 89.6% (288/317). At the end of the EDVC, influenza vaccination coverage was 572 (284 + 288)/868 (65.9%). The delay between arrival at the ED and seeing the triage nurse and physician as well as the overall ED length of stay were not modified during the study period and before and during EDVC. EDVC effectively doubled the influenza vaccination coverage, without modifying ED time interval quality indicators.

Keywords

Influenza Seasonal epidemic Vaccination Coverage Evaluation Interventional study 

Notes

Acknowledgements

We would like to thank Jeffrey Arsham for having reviewed the English language text.

ED-Study Group on Respiratory Viruses: Julien Bernard, MD; Anne Casaubieilh, Nurse Practitioner; Abigael Debit, MD; Elise Dupeyrat, MD; Yoan Gil, MD; Madline Gillo, Nurse Practitioner; Suzanne Goncalves, Nurse Practitioner; Neila Laurent, Head Staff Nurse; Michèle Macaux, Head Staff Nurse; Jeanne Pigeau, Head Staff Nurse; Ranaivoson Michel, MD; Sabrina Rouleau, Head Staff Nurse; Lydia Roux, Head Staff Nurse.

Author contributions

EC, AG, DB, SA, PhK CC and LP conceived the study and designed the trial. EC, AG, DB, SA, PhK CC and LP supervised the conduct of the trial and data collection. EC, AG, DB, SA, PhK CC and LP undertook recruitment of patients and managed the data, including quality control. EC, AG, DB and SA provided statistical advice on study design and analysed the data. EC, AG, DB and PhK drafted the manuscript, and all authors contributed substantially to its revision. EC takes responsibility for the paper as a whole.

Funding

None.

Compliance with ethical standards

Conflict of interest

None.

Statements on human and animal rights

The protocol was conducted in agreement with the Helsinki declaration. This dataset was completely anonymous and did not contain any identifiable personal health information. This study was approved by the ED (Assistance Publique-Hôpitaux de Paris) committees on ethics, research and informatics.

Informed consent

Patient informed consent was obtained before study inclusion.

References

  1. 1.
    Cheng PY, Palekar R, Azziz-Baumgartner E, Iuliano D, Alencar AP, Bresee J et al (2015) Burden of influenza-associated deaths in the Americas, 2002–2008. Influenza Other Respir Viruses 9:13–21CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Rosselli R, Martini M, Fluad Effect Working Group, Bragazzi NL, Watad A (2017) The public health impact of the so-called “Fluad effect” on the 2014/2015 influenza vaccination campaign in Italy: ethical implications for health-care workers and health communication practitioners. Adv Exp Med Biol 973:125–134CrossRefPubMedGoogle Scholar
  3. 3.
    Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA et al (2010) Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 59:1–62PubMedGoogle Scholar
  4. 4.
    US Department of Health and Human Services (2016) Immunization and infectious diseases. https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases/objectives. Accessed 11 July 2017
  5. 5.
    Direction Générale de la Santé (2012) Comité technique des vaccinations. Guide des vaccinations. http://solidarites-sante.gouv.fr/IMG/pdf/Guide_des_vaccinations_edition_2012.pdf. Accessed 14 Nov 2017
  6. 6.
    European Centre for Disease Prevention and Control (2016) Influenza. http://ecdc.europa.eu/en/healthtopics/influenza/Pages/home.aspx. Accessed 02 July 2017
  7. 7.
    Centers for Disease Control and Prevention (2016) Flu vaccination coverage. United States, 2014–15 influenza season. http://www.cdc.gov/flu/fluvaxview/coverage-1415estimates.htm. Accessed 11 July 2017
  8. 8.
    Palache A, Oriol-Mathieu V, Abelin A, Music T (2014) Influenza vaccine supply task force (IFPMA IVS). Seasonal influenza vaccine dose distribution in 157 countries (2004–2011). Vaccine 32:6369–6376CrossRefPubMedGoogle Scholar
  9. 9.
    Dexter LJ, Teare MD, Dexter M, Siriwardena AN, Read RC (2012) Strategies to increase influenza vaccination rates: outcomes of a nationwide cross-sectional survey of UK general practice. BMJ Open 11:2Google Scholar
  10. 10.
    Bechini A, Bonanni P, Lauri S, Tiscione E, Levi M, Prato R et al (2017) Strategies and actions of multi-purpose health communication on vaccine preventable infectious diseases in order to increase vaccination coverage in the population: the ESCULAPIO project. Hum Vaccines Immunother 13:369–375CrossRefGoogle Scholar
  11. 11.
    Antón F, Richart MJ, Serrano S, Martínez AM, Pruteanu DF (2016) Strategies to improve influenza vaccination coverage in Primary Health Care. Semergen 42:147–151CrossRefPubMedGoogle Scholar
  12. 12.
    Lin CJ, Nowalk MP, Pavlik VN, Brown AE, Zhang S, Raviotta JM et al (2016) Using the 4 pillars™ practice transformation program to increase adult influenza vaccination and reduce missed opportunities in a randomized cluster trial. BMC Infect Dis 16:623CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Rodriguez RM, Baraff LJ (1993) Emergency Department immunization of the elderly with pneumococcal and influenza vaccines. Ann Emerg Med 22:1729–1732CrossRefPubMedGoogle Scholar
  14. 14.
    Wrenn K, Zeldin M, Miller O (1994) Influenza and pneumococcal vaccination in the Emergency Department: is it feasible? J Gen Intern Med 9(8):425–429CrossRefPubMedGoogle Scholar
  15. 15.
    Slobodkin D, Kitlas J, Zielske P (1998) Opportunities not missed—systematic influenza and pneumococcal immunization in a public inner-city Emergency Department. Vaccine 16(19):1795–1802CrossRefPubMedGoogle Scholar
  16. 16.
    Rimple D, Weiss SJ, Brett M, Ernst AA (2006) An Emergency Department-based vaccination program: overcoming the barriers for adults at high risk for vaccine-preventable diseases. Acad Emerg Med 13(9):922–930PubMedGoogle Scholar
  17. 17.
    Grohskopf LA, Sokolow LZ, Broder KR, Olsen SJ, Karron RA, Jernigan DB et al (2016) Prevention and control of seasonal influenza with vaccines. MMWR Recomm Rep 65:1–54CrossRefPubMedGoogle Scholar
  18. 18.
    Assurance Maladie (2016) Grippe saisonnière. La campagne nationale de vaccination contre la grippe saisonnière se déroule du 6 octobre 2016 au 31 janvier 2017. Le point sur la campagne, le dispositif mis en place et les modalités pratiques. http://www.ameli.fr/professionnels-de-sante/infirmiers/exercer-au-quotidien/vaccination-contre-la-grippe-saisonniere/la-campagne-de-vaccination-2016-2017.php. Accessed 16 Nov 2017
  19. 19.
    Centers for Disease Control and Prevention (2016) Flu vaccination coverage. United States, 2014–15 influenza season. http://www.cdc.gov/flu/fluvaxview/coverage-1415estimates.htm. Accessed 12 Jul 2017
  20. 20.
    Park E, Cho M, Ki CS (2009) Correct use of repeated measures analysis of variance. Korean J Lab Med 29(1):1–9CrossRefPubMedGoogle Scholar
  21. 21.
    Nicand E (2015) Couverture vaccinale en France en 2014: un bilan contrasté. https://www.mesvaccins.net/web/news/6140-couverture-vaccinale-en-france-en-2014-un-bilan-contraste. Accessed 01 July 2017
  22. 22.
    Maurer J (2016) Inspecting the mechanism: a longitudinal analysis of socioeconomic status differences in perceived influenza risks, vaccination intentions, and vaccination behaviors during the 2009–2010 influenza pandemic. Med Decis Mak 36:887–899CrossRefGoogle Scholar
  23. 23.
    Jiménez-García R, Rodríguez-Rieiro C, Hernandez-Barrera V, Carrasco Garrido P, López de Andres A, Esteban-Vasallo MD et al (2014) Negative trends from 2008/9 to 2011/12 seasons in influenza vaccination coverages among high risk subjects and health care workers in Spain. Vaccine 32:350–354CrossRefPubMedGoogle Scholar
  24. 24.
    Zimmerman RK, Brown AE, Pavlik VN, Moehling KK, Raviotta JM, Lin CJ et al (2017) Using the 4 pillars practice transformation program to increase pneumococcal immunizations for older adults: a cluster-randomized trial. J Am Geriatr Soc 65:114–122CrossRefPubMedGoogle Scholar
  25. 25.
    Nowalk MP, Lin CJ, Pavlik VN, Brown AE, Zhang S, Moehling KK et al (2016) Using the 4 Pillars™ practice transformation program to increase adult Tdap immunization in a randomized controlled cluster trial. Vaccine 34:5026–5033CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Vermeulen MJ, Guttmann A, Stukel TA, Kachra A, Sivilotti ML, Rowe BH et al (2016) Are reductions in Emergency Department length of stay associated with improvements in quality of care? A difference-in-differences analysis. BMJ Qual Saf 25:489–498CrossRefPubMedGoogle Scholar

Copyright information

© SIMI 2018

Authors and Affiliations

  • Enrique Casalino
    • 1
    • 2
    • 3
    • 4
  • Aiham Ghazali
    • 1
    • 2
    • 3
  • Donia Bouzid
    • 1
    • 2
    • 3
  • Stephanie Antoniol
    • 1
    • 2
    • 3
  • Philippe Kenway
    • 1
  • Laurent Pereira
    • 1
  • Christophe Choquet
    • 1
  • Emergency Department Study Group on Respiratory Viruses
  1. 1.Emergency Department, Assistance Publique-Hôpitaux de Paris (AP-HP)Groupe Universitaire Paris Nord Val de SeineParisFrance
  2. 2.EA 7334, “Recherche Clinique Coordonnée Ville-Hôpital, Méthodologies et Société (REMES)”, Sorbonne Paris CitéUniversité Paris DiderotParisFrance
  3. 3.Study Group for Efficiency and Quality of Emergency Departments and Non-Scheduled Activities DepartmentsParisFrance
  4. 4.Hôpital BichatParisFrance

Personalised recommendations